| 000 | 01805 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514183624.0 | ||
| 264 | 0 | _c20040607 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2004.04899.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Zimaity, Maha M T | |
| 245 | 0 | 0 |
_aResults of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cApr 2004 |
||
| 300 |
_a187-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aChromosomes, Human _xgenetics |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKantarjian, Hagop | |
| 700 | 1 | _aTalpaz, Moshe | |
| 700 | 1 | _aO'Brien, Susan | |
| 700 | 1 | _aGiles, Francis | |
| 700 | 1 | _aGarcia-Manero, Guillermo | |
| 700 | 1 | _aVerstovsek, Srdan | |
| 700 | 1 | _aThomas, Deborah | |
| 700 | 1 | _aFerrajoli, Alessandra | |
| 700 | 1 | _aHayes, Kimberly | |
| 700 | 1 | _aNebiyou Bekele, B | |
| 700 | 1 | _aZhou, Xian | |
| 700 | 1 | _aRios, Mary B | |
| 700 | 1 | _aGlassman, Armand B | |
| 700 | 1 | _aCortes, Jorge E | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 125 _gno. 2 _gp. 187-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2004.04899.x _zAvailable from publisher's website |
| 999 |
_c14775257 _d14775257 |
||